Savaysa, New Factor Xa Blood Thinner, To Hit Market With Black Box Warning
A new blood thinner approved by the FDA carries a black box warning that it may be less effective in patients with normal kidney functions.
A new blood thinner approved by the FDA carries a black box warning that it may be less effective in patients with normal kidney functions.
The blood thinner Pradaxa has been linked to about 50 deaths in its first year on the market, according to its manufacturer, Boehringer Ingelheim.